除了这个博客，我们还运营了一个 瑞士。工作 瑞士服务平台.
瑞士是医药强国。但这一优势正日益成为一种挑战。药品价格上涨不仅影响医疗保险公司和患者，还会影响整个医疗保健体系——从保费到政治辩论。.
从长远来看，如何平衡创新、公平价格和可及性是一个值得探讨的问题。瑞士正面临着经济实力和社会责任之间的两难境地。找到解决方案并非易事，但却势在必行——否则，最终每个人都将付出远超预期的代价。.
了解 schweiz.blog 的更多信息
订阅后即可通过电子邮件收到最新文章。
We've detected you might be speaking a different language. Do you want to change to:
German German 
English (United States)
Chinese (China)
Chinese (Hong Kong)
Chinese (Taiwan)
French
Italian
Japanese
Portuguese
Spanish
Tamil
Albanian
Croatian
Czech
Dutch
Greek
Indonesian
Korean
Luxembourgish
Moroccan Arabic
Arabic
Serbian
English (UK)
English (Australia)
English (Canada)
English (New Zealand)
English (South Africa)
Swedish
Vietnamese
Ukrainian
Turkish
Thai
Russian
Romanian
Polish
Panjabi
Finnish
Norwegian
Persian